Patients with multiple sclerosis (MS) who exhibit new lesions early on in their disease experience relatively fast thinning of the ganglion cell and inner plexiform (GCIP) layers of the retina, a new study has found.

The findings are important because it may be useful to include patients with accelerated GCIP thinning in future clinical trials that test MS therapies, said study author Peter A. Calabresi, MD, professor, neurology, and director, MS Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.

http://www.medscape.com/viewarticle/776691?src=nl_topic